| The Mycobactin biosynthesis pathway: A prospective therapeutic target in the battle against tuberculosis M Shyam, D Shilkar, H Verma, A Dev, BN Sinha, F Brucoli, S Bhakta, ... Journal of Medicinal Chemistry 64 (1), 71-100, 2020 | 41 | 2020 |
| Non-carboxylic acid inhibitors of aldose reductase based on N-substituted thiazolidinedione derivatives MUM Siddique, A Thakur, D Shilkar, S Yasmin, D Halakova, L Kovacikova, ... European journal of medicinal chemistry 223, 113630, 2021 | 19 | 2021 |
| Approaches for targeting the mycobactin biosynthesis pathway for novel anti-tubercular drug discovery: Where we stand M Shyam, D Shilkar, G Rakshit, V Jayaprakash Expert opinion on drug discovery 17 (7), 699-715, 2022 | 16 | 2022 |
| A short survey of dengue protease inhibitor development in the past 6 years (2015–2020) with an emphasis on similarities between DENV and SARS-CoV-2 proteases S Murtuja, D Shilkar, B Sarkar, BN Sinha, V Jayaprakash Bioorganic & Medicinal Chemistry 49, 116415, 2021 | 13 | 2021 |
| Anticancer agents based on Plastoquinone analogs with N-phenylpiperazine: Structure-activity relationship and mechanism of action in breast cancer cells AT Jannuzzi, M Yıldız, N Bayrak, H Yıldırım, D Shilkar, V Jayaprakash, ... Chemico-Biological Interactions 349, 109673, 2021 | 11 | 2021 |
| Exploration of brominated Plastoquinone analogs: Discovery and structure-activity relationships of small antimicrobial lead molecules M Yıldız, N Bayrak, H Yıldırım, E Mataracı-Kara, D Shilkar, V Jayaprakash, ... Bioorganic Chemistry 116, 105316, 2021 | 7 | 2021 |
| Carbonic anhydrase inhibitory activity of phthalimide-capped benzene sulphonamide derivatives D Shilkar, MU Mohd Siddique, S Bua, S Yasmin, M Patil, AK Timiri, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2235089, 2023 | 5 | 2023 |
| Brain permeable curcumin-based pyrazoline analogs: MAO inhibitory and antioxidant activity VN Badavath, A Thakur, D Shilkar, C Nath, O Acevedo, G Ucar, ... Journal of Molecular Structure 1268, 133681, 2022 | 5 | 2022 |
| Aminated Quinolinequinones as Privileged Scaffolds for Antibacterial Agents: Synthesis, In Vitro Evaluation, and Putative Mode of Action H Yıldırım, N Bayrak, M Yıldız, E Mataracı-Kara, S Korkmaz, D Shilkar, ... ACS omega 7 (46), 41915-41928, 2022 | 5 | 2022 |
| Highly Active Small Aminated Quinolinequinones against Drug-Resistant Staphylococcus aureus and Candida albicans H Yıldırım, N Bayrak, M Yıldız, FN Yılmaz, E Mataracı-Kara, D Shilkar, ... Molecules 27 (9), 2923, 2022 | 5 | 2022 |
| UHPLC‐ESI‐QTOF‐MS/MS Based Identification, Quantification, and Assessment of in Silico Molecular Interactions of Major Phytochemicals from Bioactive Fractions of Clerodendrum … P Kumar Deb, D Shilkar, B Sarkar Chemistry & Biodiversity 19 (10), e202200617, 2022 | 3 | 2022 |
| Exploring the anticancer effects of brominated plastoquinone analogs with promising cytotoxic activity in MCF-7 breast cancer cells via cell cycle arrest and oxidative stress … AT Jannuzzi, AM Yilmaz Goler, N Bayrak, M Yıldız, H Yıldırım, ... Pharmaceuticals 15 (7), 777, 2022 | 3 | 2022 |
| Molecular determinants, clinical manifestations and effects of immunization on cardiovascular health during COVID-19 pandemic era-a review A Chatterjee, R Saha, A Mishra, D Shilkar, V Jayaprakash, P Sharma, ... Current Problems in Cardiology, 101250, 2022 | 2 | 2022 |
| Cytotoxic activity of quinolinequinones in cancer: In vitro studies, molecular docking, and ADME/PK profiling AT Jannuzzi, AM Yilmaz Goler, D Shilkar, S Mondal, VN Basavanakatti, ... Chemical Biology & Drug Design 102 (5), 1133-1154, 2023 | 1 | 2023 |
| Discovery of quinolinequinones with N-phenylpiperazine by conversion of hydroxyquinoline as a new class of antimicrobial agents targeting resistant pathogenic microorganisms M Yıldız, N Bayrak, H Yıldırım, SM Çakmak, FN Yılmaz, E Mataracı-Kara, ... Bioorganic Chemistry 128, 106045, 2022 | 1 | 2022 |
| A Critical Observation on the Design and Development of Reported Peptide Inhibitors of DENV NS2B-NS3 Protease in the Last Two Decades S Murtuja, D Shilkar, B Sarkar, BN Sinha, V Jayaprakash Mini Reviews in Medicinal Chemistry 22 (8), 1108-1130, 2022 | | 2022 |
| Identification of Dengue NS2B-NS3 Protease Inhibitors Through High-Throughput Virtual Screening—Impacts on Drug Development Against the Dengue Virus S Murtuja, D Shilkar, B Sarkar, BN Sinha, V Jayaprakash Human Viruses: Diseases, Treatments and Vaccines: The New Insights, 93-120, 2021 | | 2021 |
| Design and Development of Dengue Protease Inhibitors M Sheikh, D Shilkar, V Jayaprakash, B Sarkar, BN Sinha Proceedings of International Conference on Drug Discovery (ICDD), 2020 | | 2020 |
| Design and Development of Dengue NS5 Methyltransferase Inhibitors S Kumari, MG Moazzam, D Shilkar, V Jayaprakash Proceedings of International Conference on Drug Discovery (ICDD), 2020 | | 2020 |
